|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$85,165
|
N/A
|
National Institutes of Health
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
$2,184,301
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
$5,814
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
$36,888
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
$36,709
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
$358,389
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$4,275
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$6,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$79,367
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
$301,545
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
|
5R01CA207237-03
|
$395,166
|
$395,166
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
$1,276,800
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
$30,265
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$4,987
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
5R01CA194090-03
|
$341,981
|
$341,981
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
$69,718
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$592,688
|
$59,269
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Corn Farming Study
|
ZIA CP010119 02075
|
$20,212
|
$3,032
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Agricultural Cohort Consortium
|
ZIA CP010119 10537
|
$45,135
|
$2,257
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Pooling project of NCI and Cross-Canada studies
|
ZIA CP010119 10649
|
$80,847
|
$12,127
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Mayo Clinic Multiple Myeloma SPORE
|
5P50CA186781-04
|
$2,538,499
|
$2,538,499
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
Mutations that Distinguish Benign from Malignant Plasma Cell Neoplasams
|
5R01CA195688-03
|
$379,725
|
$379,725
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$12,585
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Permethrin exposure in NHANES
|
ZIA CP010125 10695
|
$75,640
|
$37,820
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Follow-up studies from the NHL/LM GWAS
|
ZIA CP010136 10799
|
$47,640
|
$4,764
|
Berndt, Sonja
|
DCEG (NCI)
|
|
PLCO - Lymphoma
|
ZIA CP010152 10709
|
$72,766
|
$14,553
|
Berndt, Sonja
|
DCEG (NCI)
|
|
ATBC Lymphoma Studies
|
ZIA CP010195 10733
|
$96,076
|
$38,430
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Cohort Consortium BMI pooling
|
ZIA CP010219 10435
|
$99,701
|
$24,925
|
Berrington, Amy
|
DCEG (NCI)
|
|
Radiobiology Outreach
|
ZIA CP010222 10441
|
$66,403
|
$3,320
|
Berrington, Amy
|
DCEG (NCI)
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
$64,993
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
$20,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
$161,476
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer
|
5R50CA211399-03
|
$264,110
|
$66,028
|
BIRD, GREGORY
|
DANA-FARBER CANCER INST
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S1
|
$52,084
|
$4,167
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S2
|
$72,961
|
$5,837
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S3
|
$91,218
|
$7,297
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S4
|
$45,500
|
$3,640
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S5
|
$198,945
|
$15,916
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-46
|
$5,104,077
|
$408,326
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-05S1
|
$670,913
|
$13,418
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
$172,512
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$433,273
|
$21,664
|
Blumberg, Peter
|
CCR (NCI)
|
|
The Role of CD86 in Multiple Myeloma
|
5R01CA192844-03
|
$347,673
|
$347,673
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Molecular characterization of myeloma and related asymptomatic precursor states
|
5R01CA186646-05
|
$263,388
|
$263,388
|
BROWN, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Total relevant funding to Multiple Myeloma for this search: $61,479,626
|